Ondansetron Injection, Solution
Product Images NDC 0409-4755

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0409-4755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetron 01)

Chemical structure of Ondansetron showing its molecular framework including methyl groups and associated hydrochloride dihydrate form.*

FDA Label Image

Logo (Ondansetron 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Label for Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL) single-dose vial. The label indicates the product is for prescription use only, should be protected from light, and is distributed by Hospira, Inc., Lake Forest, IL. The NDC number 0409-4755-18 is shown along with a barcode.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) solution in single-dose fliptop vials. The carton contains 25 vials and is labeled for sterile injection by Hospira, Inc. It includes storage instructions and references the active ingredient ondansetron hydrochloride dihydrate and sodium chloride among other components.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Ondansetron Injection, USP 40 mg/20 mL (2 mg/mL) multi-dose vial label for intravenous or intramuscular injection by Hospira, Inc. The label includes drug composition, storage instructions, NDC 0409-4759-01, and mentions the solution is sterile and for prescription use only.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Packaging label for Ondansetron Injection, USP 40 mg/20 mL (2 mg/mL) multi-dose vial by Hospira, Inc. The label indicates the product is sterile and intended for intravenous or intramuscular injection. Storage instructions specify keeping the product at 20 to 25°C, with optional refrigeration at 2 to 8°C, and protection from light.*

FDA Label Image

Principal Display Panel (20 mL Vial Tray)

Ondansetron Injection USP 40 mg per 20 mL (2 mg/mL) multi-dose vial label. The label indicates use for intravenous or intramuscular injection and is packaged by Hospira, Inc. The vial contains 20 mL solution with 10 units per package, marked as prescription only. Storage and ingredient details are included on side panels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.